We're so glad you're here! This site is to help anyone diagnosed with Medullary Thyroid Cancer and their caregivers find valuable information and support. If you'd like to connect with others with MTC, please consider joining our very active Facebook Group. You don't have to go through this alone!
If you don't yet have a copy, please download the American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma, aka "The Guidelines." This is the MTC Bible. Read it and know it and it will help you and your doctor ensure you get the proper treatment.
Lastly, please consider looking into being seen by an MTC expert. We do our best to keep a running list of what we call "Centers of Excellence." These are doctors and facilities that are properly trained and experienced enough to treat MTC patients. It's one of the most important decisions you can make on your journey.
"Unlike conventional therapies designed for cancers arising in a specific organ, selpercatinib targets the RET gene fusion itself-a rare genomic ..."
"AbstractObjectives. Erectile dysfunction (ED) is observed during treatment with the highly selective RET inhibitor selpercatinib."
"Watch the Lung Cancers Today interview and learn more." LIBRETTO-432 Trial at ASCO 2026 Plenary Session: Adjuvant Selpercatinib in RET Fusion-Positive ..."
"A Retrospective Study to Identify Factors Associated with Aggressive Medullary Thyroid Cancer."
"Selpercatinib, also known as Retevmo, targets and "turns off" the RET gene fusion to stop cell growth, according to a July 21 news release from ..."
This website is intended for educational purposes only. It is not intended, nor should it be interpreted, as medical advice or instructions of any kind. Readers are advised to consult their own medical doctor(s) for all matters involving their health and medical care.